Global Crocin Market Size study, by Application (Food, Drug), Purity (Purity >98%, Purity <98%), Indication (Pain), Distribution Channel (Hospital Pharmacy) and Regional Forecasts 2022-2032
Global Crocin Market is valued approximately at USD 4.77 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.14% over the forecast period 2024-2032. Crocin, a natural carotenoid compound primarily derived from saffron (Crocus sativus), has gained considerable traction in the pharmaceutical and nutraceutical industries owing to its multifaceted bioactive properties. Known for its potent antioxidant, neuroprotective, and anti-inflammatory effects, crocin is predominantly utilized in pain management applications, especially for conditions related to neurodegenerative disorders, headaches, and inflammatory diseases. With a growing shift toward plant-based compounds in drug formulations and functional foods, crocin is fast becoming a pivotal ingredient for manufacturers targeting wellness-oriented consumers and pharmaceutical innovations alike.
The escalating demand for natural analgesics and anti-inflammatory solutions has significantly propelled interest in crocin-based products. The food and drug sectors, in particular, are witnessing an upward curve in the integration of crocin for both therapeutic and preventive applications. Research suggests that crocin’s ability to modulate oxidative stress and neurotransmitter balance positions it as a promising candidate for chronic pain relief without the adverse side effects associated with synthetic pharmaceuticals. Furthermore, increasing consumer inclination towards clean-label, organic, and botanical-based health interventions continues to bolster the product’s marketability. However, challenges such as variability in saffron yield, high raw material costs, and stringent purity standards have impeded the scalability of crocin production—especially in markets relying heavily on natural extraction.
Market players are increasingly exploring advanced purification technologies and bioengineering approaches to extract high-purity crocin (>98%) more efficiently. This shift is enabling broader applications across regulated pharmaceutical settings, where efficacy and consistency are paramount. The move toward standardizing crocin for pharmaceutical-grade uses has attracted attention from global regulatory bodies and contract manufacturers, thereby opening avenues for clinical trials and drug formulation partnerships. In addition, companies are integrating crocin into functional food and beverage formats, broadening its appeal across consumer demographics. These innovations, paired with strategic collaborations, are transforming crocin from a traditional remedy into a scientifically validated therapeutic asset.
Regionally, the market demonstrates a varied growth pattern driven by consumption trends and cultivation capabilities. Asia Pacific, particularly countries like India and Iran, leads the charge due to the region's dominance in saffron production and its deep-rooted history in traditional medicine. Europe is also a significant contributor, with robust demand in pharmaceutical applications and increasing regulatory support for botanical extracts. North America is rapidly catching up, propelled by rising consumer awareness, higher R&D investment, and evolving wellness trends. Meanwhile, Latin America and the Middle East & Africa are emerging markets showing promise, particularly where saffron cultivation and herbal medicine are gaining renewed interest from health ministries and local biotech players.
Major market player included in this report are:
By Application
North America
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
The escalating demand for natural analgesics and anti-inflammatory solutions has significantly propelled interest in crocin-based products. The food and drug sectors, in particular, are witnessing an upward curve in the integration of crocin for both therapeutic and preventive applications. Research suggests that crocin’s ability to modulate oxidative stress and neurotransmitter balance positions it as a promising candidate for chronic pain relief without the adverse side effects associated with synthetic pharmaceuticals. Furthermore, increasing consumer inclination towards clean-label, organic, and botanical-based health interventions continues to bolster the product’s marketability. However, challenges such as variability in saffron yield, high raw material costs, and stringent purity standards have impeded the scalability of crocin production—especially in markets relying heavily on natural extraction.
Market players are increasingly exploring advanced purification technologies and bioengineering approaches to extract high-purity crocin (>98%) more efficiently. This shift is enabling broader applications across regulated pharmaceutical settings, where efficacy and consistency are paramount. The move toward standardizing crocin for pharmaceutical-grade uses has attracted attention from global regulatory bodies and contract manufacturers, thereby opening avenues for clinical trials and drug formulation partnerships. In addition, companies are integrating crocin into functional food and beverage formats, broadening its appeal across consumer demographics. These innovations, paired with strategic collaborations, are transforming crocin from a traditional remedy into a scientifically validated therapeutic asset.
Regionally, the market demonstrates a varied growth pattern driven by consumption trends and cultivation capabilities. Asia Pacific, particularly countries like India and Iran, leads the charge due to the region's dominance in saffron production and its deep-rooted history in traditional medicine. Europe is also a significant contributor, with robust demand in pharmaceutical applications and increasing regulatory support for botanical extracts. North America is rapidly catching up, propelled by rising consumer awareness, higher R&D investment, and evolving wellness trends. Meanwhile, Latin America and the Middle East & Africa are emerging markets showing promise, particularly where saffron cultivation and herbal medicine are gaining renewed interest from health ministries and local biotech players.
Major market player included in this report are:
- Bio-gen Extracts Pvt. Ltd.
- Sigma-Aldrich Corporation (Merck KGaA)
- Plamed Green Science Group
- Bioprex Labs
- Alpspure Lifesciences Pvt. Ltd.
- Plantnat
- Wako Pure Chemical Industries, Ltd.
- Natac Group
- Saffron Tech Ltd.
- Arjuna Natural Pvt. Ltd.
- PhytoLife Sciences Pvt. Ltd.
- Yunnan Plant Extracts Co., Ltd.
- Tocris Bioscience
- Alpspure Lifesciences
- Xi’an Greena Biotech Co., Ltd.
By Application
- Food
- Drug
- Purity >98%
- Purity <98%
- Pain
- Hospital Pharmacy
North America
- U.S.
- Canada
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Brazil
- Mexico
- Rest of Latin America
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with Country level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
- Bio-gen Extracts Pvt. Ltd.
- Sigma-Aldrich Corporation (Merck KGaA)
- Plamed Green Science Group
- Bioprex Labs
- Alpspure Lifesciences Pvt. Ltd.
- Plantnat
- Wako Pure Chemical Industries, Ltd.
- Natac Group
- Saffron Tech Ltd.
- Arjuna Natural Pvt. Ltd.
- PhytoLife Sciences Pvt. Ltd.
- Yunnan Plant Extracts Co., Ltd.
- Tocris Bioscience
- Alpspure Lifesciences
- Xi’an Greena Biotech Co., Ltd.
CHAPTER 1. GLOBAL CROCIN MARKET EXECUTIVE SUMMARY
1.1. Global Crocin Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Application
1.3.2. By Purity
1.3.3. By Indication
1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL CROCIN MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL CROCIN MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Rising preference for natural analgesics
3.1.2. Surge in chronic pain disorders
3.1.3. Consumer shift toward clean-label botanicals
3.2. Market Challenges
3.2.1. High raw material and extraction costs
3.2.2. Variability in saffron crop yields
3.3. Market Opportunities
3.3.1. Advances in bioengineering for high-purity crocin
3.3.2. Expansion into functional food and nutraceuticals
3.3.3. Growing hospital pharmacy adoption
CHAPTER 4. GLOBAL CROCIN MARKET INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Forces
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL CROCIN MARKET SIZE & FORECASTS BY APPLICATION (2022–2032)
5.1. Segment Dashboard
5.2. Global Crocin Market: {Application} Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Food
5.2.2. Drug
CHAPTER 6. GLOBAL CROCIN MARKET SIZE & FORECASTS BY PURITY (2022–2032)
6.1. Segment Dashboard
6.2. Global Crocin Market: {Purity} Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Purity >98%
6.2.2. Purity <98%
CHAPTER 7. GLOBAL CROCIN MARKET SIZE & FORECASTS BY INDICATION & DISTRIBUTION CHANNEL (2022–2032)
7.1. Indication: Pain
7.2. Distribution Channel: Hospital Pharmacy
CHAPTER 8. GLOBAL CROCIN MARKET SIZE & FORECASTS BY REGION (2022–2032)
8.1. North America Crocin Market
8.1.1. U.S. Market
8.1.2. Canada Market
8.2. Europe Crocin Market
8.2.1. UK Market
8.2.2. Germany Market
8.2.3. France Market
8.2.4. Spain Market
8.2.5. Italy Market
8.2.6. Rest of Europe Market
8.3. Asia Pacific Crocin Market
8.3.1. China Market
8.3.2. India Market
8.3.3. Japan Market
8.3.4. Australia Market
8.3.5. South Korea Market
8.3.6. Rest of Asia Pacific Market
8.4. Latin America Crocin Market
8.4.1. Brazil Market
8.4.2. Mexico Market
8.4.3. Rest of Latin America Market
8.5. Middle East & Africa Crocin Market
8.5.1. Saudi Arabia Market
8.5.2. South Africa Market
8.5.3. Rest of Middle East & Africa Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Bio-gen Extracts Pvt. Ltd.
9.1.2. Sigma-Aldrich Corporation (Merck KGaA)
9.1.3. Plamed Green Science Group
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Bio-gen Extracts Pvt. Ltd.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Sigma-Aldrich Corporation (Merck KGaA)
9.3.3. Plamed Green Science Group
9.3.4. Bioprex Labs
9.3.5. Alpspure Lifesciences Pvt. Ltd.
9.3.6. Plantnat
9.3.7. Wako Pure Chemical Industries, Ltd.
9.3.8. Natac Group
9.3.9. Saffron Tech Ltd.
9.3.10. Arjuna Natural Pvt. Ltd.
9.3.11. PhytoLife Sciences Pvt. Ltd.
9.3.12. Yunnan Plant Extracts Co., Ltd.
9.3.13. Tocris Bioscience
9.3.14. Xi’an Greena Biotech Co., Ltd.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
1.1. Global Crocin Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Application
1.3.2. By Purity
1.3.3. By Indication
1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL CROCIN MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL CROCIN MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Rising preference for natural analgesics
3.1.2. Surge in chronic pain disorders
3.1.3. Consumer shift toward clean-label botanicals
3.2. Market Challenges
3.2.1. High raw material and extraction costs
3.2.2. Variability in saffron crop yields
3.3. Market Opportunities
3.3.1. Advances in bioengineering for high-purity crocin
3.3.2. Expansion into functional food and nutraceuticals
3.3.3. Growing hospital pharmacy adoption
CHAPTER 4. GLOBAL CROCIN MARKET INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Forces
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL CROCIN MARKET SIZE & FORECASTS BY APPLICATION (2022–2032)
5.1. Segment Dashboard
5.2. Global Crocin Market: {Application} Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Food
5.2.2. Drug
CHAPTER 6. GLOBAL CROCIN MARKET SIZE & FORECASTS BY PURITY (2022–2032)
6.1. Segment Dashboard
6.2. Global Crocin Market: {Purity} Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Purity >98%
6.2.2. Purity <98%
CHAPTER 7. GLOBAL CROCIN MARKET SIZE & FORECASTS BY INDICATION & DISTRIBUTION CHANNEL (2022–2032)
7.1. Indication: Pain
7.2. Distribution Channel: Hospital Pharmacy
CHAPTER 8. GLOBAL CROCIN MARKET SIZE & FORECASTS BY REGION (2022–2032)
8.1. North America Crocin Market
8.1.1. U.S. Market
8.1.2. Canada Market
8.2. Europe Crocin Market
8.2.1. UK Market
8.2.2. Germany Market
8.2.3. France Market
8.2.4. Spain Market
8.2.5. Italy Market
8.2.6. Rest of Europe Market
8.3. Asia Pacific Crocin Market
8.3.1. China Market
8.3.2. India Market
8.3.3. Japan Market
8.3.4. Australia Market
8.3.5. South Korea Market
8.3.6. Rest of Asia Pacific Market
8.4. Latin America Crocin Market
8.4.1. Brazil Market
8.4.2. Mexico Market
8.4.3. Rest of Latin America Market
8.5. Middle East & Africa Crocin Market
8.5.1. Saudi Arabia Market
8.5.2. South Africa Market
8.5.3. Rest of Middle East & Africa Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Bio-gen Extracts Pvt. Ltd.
9.1.2. Sigma-Aldrich Corporation (Merck KGaA)
9.1.3. Plamed Green Science Group
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Bio-gen Extracts Pvt. Ltd.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Sigma-Aldrich Corporation (Merck KGaA)
9.3.3. Plamed Green Science Group
9.3.4. Bioprex Labs
9.3.5. Alpspure Lifesciences Pvt. Ltd.
9.3.6. Plantnat
9.3.7. Wako Pure Chemical Industries, Ltd.
9.3.8. Natac Group
9.3.9. Saffron Tech Ltd.
9.3.10. Arjuna Natural Pvt. Ltd.
9.3.11. PhytoLife Sciences Pvt. Ltd.
9.3.12. Yunnan Plant Extracts Co., Ltd.
9.3.13. Tocris Bioscience
9.3.14. Xi’an Greena Biotech Co., Ltd.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
LIST OF TABLES
TABLE 1. Global Crocin market, report scope
TABLE 2. Global Crocin market estimates & forecasts by Region 2022–2032 (USD Million)
TABLE 3. Global Crocin market estimates & forecasts by Application 2022–2032 (USD Million)
TABLE 4. Global Crocin market estimates & forecasts by Purity 2022–2032 (USD Million)
TABLE 5. Global Crocin market estimates & forecasts by Indication 2022–2032 (USD Million)
TABLE 6. Global Crocin market estimates & forecasts by Distribution Channel 2022–2032 (USD Million)
TABLE 7. Global Crocin market by segment, estimates & forecasts, 2022–2032 (USD Million)
TABLE 8. North America Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 9. U.S. Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 10. Canada Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 11. Europe Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 12. UK Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 13. Germany Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 14. Asia Pacific Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 15. China Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 16. India Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 17. Latin America Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 18. Brazil Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 19. Middle East & Africa Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 20. Company market share analysis (2023)
TABLE 1. Global Crocin market, report scope
TABLE 2. Global Crocin market estimates & forecasts by Region 2022–2032 (USD Million)
TABLE 3. Global Crocin market estimates & forecasts by Application 2022–2032 (USD Million)
TABLE 4. Global Crocin market estimates & forecasts by Purity 2022–2032 (USD Million)
TABLE 5. Global Crocin market estimates & forecasts by Indication 2022–2032 (USD Million)
TABLE 6. Global Crocin market estimates & forecasts by Distribution Channel 2022–2032 (USD Million)
TABLE 7. Global Crocin market by segment, estimates & forecasts, 2022–2032 (USD Million)
TABLE 8. North America Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 9. U.S. Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 10. Canada Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 11. Europe Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 12. UK Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 13. Germany Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 14. Asia Pacific Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 15. China Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 16. India Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 17. Latin America Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 18. Brazil Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 19. Middle East & Africa Crocin market estimates & forecasts, 2022–2032 (USD Million)
TABLE 20. Company market share analysis (2023)
LIST OF FIGURES
FIG 1. Global Crocin market, research methodology
FIG 2. Global Crocin market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Crocin market, key trends 2023
FIG 5. Global Crocin market, growth prospects 2022–2032
FIG 6. Global Crocin market, Porter’s Five Forces model
FIG 7. Global Crocin market, PESTEL analysis
FIG 8. Global Crocin market, value chain analysis
FIG 9. Global Crocin market by segment, 2022 & 2032 (USD Million)
FIG 10. Global Crocin market by segment, 2022 & 2032 (USD Million)
FIG 11. Global Crocin market by segment, 2022 & 2032 (USD Million)
FIG 12. Global Crocin market by segment, 2022 & 2032 (USD Million)
FIG 13. Global Crocin market by segment, 2022 & 2032 (USD Million)
FIG 14. Global Crocin market, regional snapshot 2022 & 2032
FIG 15. North America Crocin market 2022 & 2032 (USD Million)
FIG 16. Europe Crocin market 2022 & 2032 (USD Million)
FIG 17. Asia-Pacific Crocin market 2022 & 2032 (USD Million)
FIG 18. Latin America Crocin market 2022 & 2032 (USD Million)
FIG 19. Middle East & Africa Crocin market 2022 & 2032 (USD Million)
FIG 20. Global Crocin market, company market share analysis (2023)
FIG 1. Global Crocin market, research methodology
FIG 2. Global Crocin market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Crocin market, key trends 2023
FIG 5. Global Crocin market, growth prospects 2022–2032
FIG 6. Global Crocin market, Porter’s Five Forces model
FIG 7. Global Crocin market, PESTEL analysis
FIG 8. Global Crocin market, value chain analysis
FIG 9. Global Crocin market by segment, 2022 & 2032 (USD Million)
FIG 10. Global Crocin market by segment, 2022 & 2032 (USD Million)
FIG 11. Global Crocin market by segment, 2022 & 2032 (USD Million)
FIG 12. Global Crocin market by segment, 2022 & 2032 (USD Million)
FIG 13. Global Crocin market by segment, 2022 & 2032 (USD Million)
FIG 14. Global Crocin market, regional snapshot 2022 & 2032
FIG 15. North America Crocin market 2022 & 2032 (USD Million)
FIG 16. Europe Crocin market 2022 & 2032 (USD Million)
FIG 17. Asia-Pacific Crocin market 2022 & 2032 (USD Million)
FIG 18. Latin America Crocin market 2022 & 2032 (USD Million)
FIG 19. Middle East & Africa Crocin market 2022 & 2032 (USD Million)
FIG 20. Global Crocin market, company market share analysis (2023)
